CNTMF Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.08
Previous CloseN/A
Volume17.55K
Average Volume (3M)298.25K
Market Cap
$12.88M
Enterprise Value$137.61
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding613,471,100
10 Day Avg. Volume366,269
30 Day Avg. Volume298,254
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cansortium News
CNTMF FAQ
What was Cansortium’s price range in the past 12 months?
Cansortium lowest stock price was $0.02 and its highest was $0.08 in the past 12 months.
What is Cansortium’s market cap?
Cansortium’s market cap is $12.88M.
When is Cansortium’s upcoming earnings report date?
Cansortium’s upcoming earnings report date is Dec 01, 2026 which is in 95 days.
How were Cansortium’s earnings last quarter?
Currently, no data Available
Is Cansortium overvalued?
According to Wall Street analysts Cansortium’s price is currently Overvalued.
Does Cansortium pay dividends?
Cansortium does not currently pay dividends.
What is Cansortium’s EPS estimate?
Cansortium’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cansortium have?
Cansortium has 613,471,100 shares outstanding.
What happened to Cansortium’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cansortium?
Currently, no hedge funds are holding shares in CNTMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cansortium
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.